The Feasibility and Clinical Efficacy of Atezolizumab Consolidation Treatment in High Risk (IPI > 2) DLBCL
Clinical trial NCT03463057 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03463057
- Sponsor
- Stichting Hemato-Oncologie voor Volwassenen Nederland
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-30
- Primary completion
- 2024-01-18
- Enrollment
- 109
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.